trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Progeria D011371 3 associated lipids
Mastocytoma D034801 3 associated lipids
Uveal Neoplasms D014604 3 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Lymphoma, Large-Cell, Anaplastic D017728 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Wang X et al. Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. 2009 Cancer Res. pmid:19752087
Hirata H et al. Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. 2009 Clin. Cancer Res. pmid:19755393
Kong X et al. HDAC2 deacetylates class II transactivator and suppresses its activity in macrophages and smooth muscle cells. 2009 J. Mol. Cell. Cardiol. pmid:19041327
Rossi M et al. Caspase cleavage of Itch in chronic lymphocytic leukemia cells. 2009 Biochem. Biophys. Res. Commun. pmid:19073138
Niu F et al. Trichostatin A enhances OGD-astrocyte viability by inhibiting inflammatory reaction mediated by NF-kappaB. 2009 Brain Res. Bull. pmid:19103266
Santiago A et al. Identification of two independent SUMO-interacting motifs in Daxx: evolutionary conservation from Drosophila to humans and their biochemical functions. 2009 Cell Cycle pmid:19106612
Kim HN et al. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. 2009 Eur. J. Pharmacol. pmid:19766111
Sugimura S et al. Interspecies somatic cell nucleus transfer with porcine oocytes as recipients: A novel bioassay system for assessing the competence of canine somatic cells to develop into embryos. 2009 Theriogenology pmid:19524287
Gregorie CJ et al. Restoration of immune response gene induction in trophoblast tumor cells associated with cellular senescence. 2009 J. Reprod. Immunol. pmid:19493573
Fujii K et al. Co-treatment with deoxycholic acid and azoxymethane accelerates secretion of HMGB1 in IEC6 intestinal epithelial cells. 2009 Cell Prolif. pmid:19614672
Łuczak MW and Jagodziński PP Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells. 2009 Biomed. Pharmacother. pmid:18602794
Auer D et al. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. 2009 Breast Cancer Res. Treat. pmid:18618240
Ai J et al. HDAC6 regulates androgen receptor hypersensitivity and nuclear localization via modulating Hsp90 acetylation in castration-resistant prostate cancer. 2009 Mol. Endocrinol. pmid:19855091
Demircan B et al. Comparative epigenomics of human and mouse mammary tumors. 2009 Genes Chromosomes Cancer pmid:18836996
Susick L et al. Regulatory roles for histone deacetylation in IL-1beta-induced nitric oxide release in pancreatic beta-cells. 2008 Sep-Oct J. Cell. Mol. Med. pmid:18053091
Li X and Bai XZ [NF-kappaB modulates activation of the BMP-2 gene by trichostatin A]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140318
Kir'ianov GI et al. [Nucleosome positioning within neomycinphosphotransferase gene (NPTII) on yeast plasmid in repressed and active state]. 2008 Nov-Dec Mol. Biol. (Mosk.) pmid:19140324
Miyoshi M et al. Short-chain fatty acids and trichostatin A alter tight junction permeability in human umbilical vein endothelial cells. 2008 Nov-Dec Nutrition pmid:18723323
Nishikiori N et al. Prevention of murine experimental corneal trauma by epigenetic events regulating claudin 6 and claudin 9. 2008 May-Jun Jpn. J. Ophthalmol. pmid:18661270
Fenic I et al. In vivo application of histone deacetylase inhibitor trichostatin-a impairs murine male meiosis. 2008 Mar-Apr J. Androl. pmid:18046049
Smetana K et al. To the nucleolar density and size in apoptotic human leukemic myeloblasts produced in vitro by Trichostatin A. 2008 Jul-Sep Eur J Histochem pmid:18840553
Kovács P and Csaba G The effect of histone deacetylase inhibitor trichostatin A (TSA) on the incorporation of 32P (Pi) and 3H-palmitic acid into the phospholipids of Tetrahymena. 2008 Jan-Feb Cell Biochem. Funct. pmid:17191269
Park H et al. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells. 2008 Int. J. Mol. Med. pmid:18949380
Lin YC et al. Effects of trichostatin A on neuronal mu-opioid receptor gene expression. 2008 Brain Res. pmid:18950606
Haffner I et al. Regulation of arginase-1 expression in macrophages by a protein kinase A type I and histone deacetylase dependent pathway. 2008 J. Cell. Biochem. pmid:17577214
Björkman M et al. Defining the molecular action of HDAC inhibitors and synergism with androgen deprivation in ERG-positive prostate cancer. 2008 Int. J. Cancer pmid:18798265
Oger F et al. The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni. 2008 Biochem. Biophys. Res. Commun. pmid:18977200
Gray SG et al. Transcriptional regulation of IRS5/DOK4 expression in non-small-cell lung cancer cells. 2008 Clin Lung Cancer pmid:19073520
Chou CW and Chen CC HDAC inhibition upregulates the expression of angiostatic ADAMTS1. 2008 FEBS Lett. pmid:19007777
Nair S et al. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. 2008 Pharm. Res. pmid:17657594
Setiadi AF et al. Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors. 2008 Cancer Res. pmid:19047136
Mizumoto S et al. The developmental potential of parthenogenetic and somatic cell nuclear-transferred rat oocytes in vitro. 2008 Cloning Stem Cells pmid:19049415
Slack MD et al. Characterizing heterogeneous cellular responses to perturbations. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:19052231
Chittur SV et al. Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism. 2008 BMC Genomics pmid:18959802
Hayashi K et al. Dynamic equilibrium and heterogeneity of mouse pluripotent stem cells with distinct functional and epigenetic states. 2008 Cell Stem Cell pmid:18940731
Ridolfi E et al. Inhibitory effect of HGF on invasiveness of aggressive MDA-MB231 breast carcinoma cells, and role of HDACs. 2008 Br. J. Cancer pmid:18941460
Tanaka M et al. The Arabidopsis histone deacetylases HDA6 and HDA19 contribute to the repression of embryonic properties after germination. 2008 Plant Physiol. pmid:18024558
Ramirez T et al. Sodium arsenite modulates histone acetylation, histone deacetylase activity and HMGN protein dynamics in human cells. 2008 Chromosoma pmid:17999076
Zhang S et al. Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3. 2008 Exp. Oncol. pmid:19112422
Malinen M et al. Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to Trichostatin A and 1alpha,25-dihydroxyvitamin D3. 2008 Nucleic Acids Res. pmid:17999998
Schäfer S et al. Phenylalanine-containing hydroxamic acids as selective inhibitors of class IIb histone deacetylases (HDACs). 2008 Bioorg. Med. Chem. pmid:18054239
Joseph RA et al. Microtubule acetylation and stability may explain alcohol-induced alterations in hepatic protein trafficking. 2008 Hepatology pmid:18161881
Shi LH et al. Trichostatin A and nuclear reprogramming of cloned rabbit embryos. 2008 J. Anim. Sci. pmid:18245503
Paris M et al. Histone deacetylase inhibitors: from bench to clinic. 2008 J. Med. Chem. pmid:18247554
Gupta MP et al. HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. 2008 J. Biol. Chem. pmid:18250163
Politis PK et al. BM88/Cend1 is involved in histone deacetylase inhibition-mediated growth arrest and differentiation of neuroblastoma cells. 2008 FEBS Lett. pmid:18258204
Isakov E et al. Trichostatin A regulates peroxiredoxin expression and virulence of the parasite Entamoeba histolytica. 2008 Mol. Biochem. Parasitol. pmid:18191469
Andrews KT et al. Potent antimalarial activity of histone deacetylase inhibitor analogues. 2008 Antimicrob. Agents Chemother. pmid:18212103
Heller G et al. Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. 2008 Cancer Res. pmid:18172295
Manning J et al. Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen-processing machinery components in a murine model for human papilloma virus 16-associated tumours. 2008 Immunology pmid:17725605
Balakrishnan L and Milavetz B HDAC inhibitors stimulate viral transcription by multiple mechanisms. 2008 Virol. J. pmid:18353181
Kimata Y et al. Diminishing HDACs by drugs or mutations promotes normal or abnormal sister chromatid separation by affecting APC/C and adherin. 2008 J. Cell. Sci. pmid:18354085
Suuronen T et al. Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. 2008 Neurochem. Res. pmid:18307035
Jiang Y et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. 2008 J. Exp. Biol. pmid:18310117
Dong G et al. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents. 2008 J. Pharmacol. Exp. Ther. pmid:18310471
Kim M et al. Epigenetic down-regulation and suppressive role of DCBLD2 in gastric cancer cell proliferation and invasion. 2008 Mol. Cancer Res. pmid:18314483
Yu C et al. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. 2008 Neuro-oncology pmid:18445700
Jensen TJ et al. Epigenetic remodeling during arsenical-induced malignant transformation. 2008 Carcinogenesis pmid:18448484
van West P et al. Internuclear gene silencing in Phytophthora infestans is established through chromatin remodelling. 2008 Microbiology (Reading, Engl.) pmid:18451057
Liu Z et al. Incubation with somatostatin, 5-aza decitabine and trichostatin up-regulates somatostatin receptor expression in prostate cancer cells. 2008 Oncol. Rep. pmid:18575731
Plouffe D et al. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. 2008 Proc. Natl. Acad. Sci. U.S.A. pmid:18579783
Sun Y et al. Modulation of transcription parameters in glucocorticoid receptor-mediated repression. 2008 Mol. Cell. Endocrinol. pmid:18583028
Tshuikina M et al. Epigenetic silencing of the interferon regulatory factor ICSBP/IRF8 in human multiple myeloma. 2008 Exp. Hematol. pmid:18922617
Hishikawa K and Fujita T [Kidney regeneration update]. 2008 Nippon Rinsho pmid:18464514
Wu X et al. Trichostatin A improved epigenetic modifications of transfected cells but did not improve subsequent cloned embryo development. 2008 Anim. Biotechnol. pmid:18855246
Kato A et al. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. 2008 Exp. Cell Res. pmid:18588874
Li J et al. High in vitro development after somatic cell nuclear transfer and trichostatin A treatment of reconstructed porcine embryos. 2008 Theriogenology pmid:18573521
Xu ZM et al. The novel gene LRP15 is regulated by DNA methylation and confers increased efficiency of DNA repair of ultraviolet-induced DNA damage. 2008 BMB Rep pmid:18377727
Chen CJ et al. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells. 2008 Eur. J. Pharmacol. pmid:18590721
Karantzali E et al. Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. 2008 Genome Biol. pmid:18394158
Marengo E et al. Evaluation of the variables characterized by significant discriminating power in the application of SIMCA classification method to proteomic studies. 2008 J. Proteome Res. pmid:18543959
Ree AH et al. HDAC2 deficiency and histone acetylation. 2008 Nat. Genet. pmid:18583969
Galiová G et al. Chromatin changes induced by lamin A/C deficiency and the histone deacetylase inhibitor trichostatin A. 2008 Eur. J. Cell Biol. pmid:18396346
Liu Y et al. Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. 2008 Cancer Invest. pmid:18584348
Geli J et al. Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. 2008 Int. J. Cancer pmid:18452173
Nakao Y et al. Evaluation of antiangiogenic activity of azumamides by the in vitro vascular organization model using mouse induced pluripotent stem (iPS) cells. 2008 Bioorg. Med. Chem. Lett. pmid:18397826
Mazitschek R et al. Development of a fluorescence polarization based assay for histone deacetylase ligand discovery. 2008 Bioorg. Med. Chem. Lett. pmid:18430569
Chen PC et al. Synthesis and structure-activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group. 2008 Bioorg. Med. Chem. pmid:18397827
Habold C et al. Trichostatin A causes p53 to switch oxidative-damaged colorectal cancer cells from cell cycle arrest into apoptosis. 2008 J. Cell. Mol. Med. pmid:18419600
Yan C et al. Comparative molecular dynamics simulations of histone deacetylase-like protein: binding modes and free energy analysis to hydroxamic acid inhibitors. 2008 Proteins pmid:18398905
Romieu P et al. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. 2008 J. Neurosci. pmid:18799668
Ko JM et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma. 2008 Mol. Cancer Res. pmid:18403638
Roy S et al. Histone deacetylase 5 represses the transcription of cyclin D3. 2008 J. Cell. Biochem. pmid:18404677
Kawamoto K et al. DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines. 2008 Int. J. Cancer pmid:18404682
Hayakawa F et al. Acetylation of PML is involved in histone deacetylase inhibitor-mediated apoptosis. 2008 J. Biol. Chem. pmid:18621739
Reilly CM et al. The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. 2008 J. Autoimmun. pmid:18650065
Law AY et al. Histone deacetylase inhibitor-induced cellular apoptosis involves stanniocalcin-1 activation. 2008 Exp. Cell Res. pmid:18652825
Bosisio D et al. Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. 2008 J. Leukoc. Biol. pmid:18780875
Yang L et al. [Effect of decitabine combined with Trichostatin A on MDS cell line SKM-1 in vitro]. 2008 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:18718068
Zou XM et al. Gastric cancer cell lines induced by trichostatin A. 2008 World J. Gastroenterol. pmid:18720545
Duan H et al. Functional long-range interactions of the IgH 3' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. 2008 Oncogene pmid:18695675
Ding X et al. Increased pre-implantation development of cloned bovine embryos treated with 5-aza-2'-deoxycytidine and trichostatin A. 2008 Theriogenology pmid:18556056
Su RC et al. Epigenetic regulation of established human type 1 versus type 2 cytokine responses. 2008 J. Allergy Clin. Immunol. pmid:17980413
Schauber J et al. Histone acetylation in keratinocytes enables control of the expression of cathelicidin and CD14 by 1,25-dihydroxyvitamin D3. 2008 J. Invest. Dermatol. pmid:17943182
Chen J et al. Cu2+ is required for pyrrolidine dithiocarbamate to inhibit histone acetylation and induce human leukemia cell apoptosis. 2008 Chem. Biol. Interact. pmid:17961528
Jin B et al. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function. 2008 Hum. Mol. Genet. pmid:18029387
Gan Y et al. Synergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cells. 2008 Biochem. Biophys. Res. Commun. pmid:17996726
Lee EJ et al. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells. 2008 Int. J. Oncol. pmid:18813790
Van Wagoner DR and Nattel S Insights into mechanisms linking cardiac hypertrophy and atrial fibrosis: evidence for a role of histone deacetylase in atrial fibrillation pathophysiology and therapy. 2008 J. Mol. Cell. Cardiol. pmid:18817781
Hitchler MJ et al. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. 2008 Free Radic. Biol. Med. pmid:18845242